Chronic kidney disease and transvenous cardiac implantable electronic device infection-is there an impact on healthcare utilization, costs, disease progression, and mortality? Posted on July 8th, 2024 by LEADconnection Post navigation Previous: Outcomes of complete removal versus conservative therapy in cardiac implantable electronic device infections – A systematic review and Meta-analysis.Next: Factors associated with cardiac implantable electronic device-related infections, New South Wales, 2016-21: a retrospective cohort study.
Outcomes of complete removal versus conservative therapy in cardiac implantable electronic device infections – A systematic review and Meta-analysis. Posted on July 8th, 2024 by LEADconnection Post navigation Previous: Prevention and Risk Assessment of Cardiac Device Infections in Clinical Practice.Next: Chronic kidney disease and transvenous cardiac implantable electronic device infection-is there an impact on healthcare utilization, costs, disease progression, and mortality?
Prevention and Risk Assessment of Cardiac Device Infections in Clinical Practice. Posted on July 8th, 2024 by LEADconnection Post navigation Previous: Trends and disparities in cardiac implantable electronic device infection-related mortality in the United StatesNext: Outcomes of complete removal versus conservative therapy in cardiac implantable electronic device infections – A systematic review and Meta-analysis.
